We are pleased to invite you to our ICML Satellite Symposium “How I Treat Hematologic Malignancy in 2011: Expert Guidance for the Clinician,” to be held on 14 June 2011 in Lugano, Switzerland.

 

During this interactive meeting, leaders in the field will discuss clinical issues in the field of hematologic malignancies.

Palazzo dei Congressi

Room A
Lugano, Switzerland

This meeting is intended for oncologists, hematologists, and other healthcare providers involved and/or interested in the management of patients with chronic lymphocytic leukemia, Waldenström macroglobulinemia, and mantle cell and follicular lymphomas.

Upon completion of this educational activity, participants should be able to:

• Describe the current treatment approaches for the patient with relapsed/refractory chronic lymphocytic leukemia and evaluate how to incorporate therapies into clinical practice
• Outline the clinical profile of Waldenström macroglobulinemia, and compare and contrast current and emerging treatment strategies for this rare B-cell disorder

• Evaluate changing outcomes in mantle cell lymphomas based on the emerging use of novel agents and antibodies

• Summarize treatment options for the management of patients with relapsed follicular lymphoma and the selection and role of maintenance therapy

Chairman
James O. Armitage, MD

University of Nebraska Medical Center

Omaha, Nebraska, USA

Faculty
Bruce D. Cheson, MD

Georgetown University Hospital

Lombardi Comprehensive Cancer Center

Washington, DC, USA

Stephan Stilgenbauer, MD

University of Ulm

Ulm, Germany

Steven Treon, MD, PhD

Dana-Farber Cancer Institute

Boston, Massachusetts, USA